WHO: the casualties and compromises of renewal
- PMID: 12047986
- DOI: 10.1016/S0140-6736(02)08523-9
WHO: the casualties and compromises of renewal
Abstract
The World Health Organization is the leading international agency in health. WHO's reputation reached a peak in the 1970s with the then director-general Halfdan Mahler's advocacy of Health for All by the Year 2000 and the successful worldwide eradication of smallpox. The 1980s and 1990s saw WHO lose much of its authority. Too easily, the blame was put on one man-Mahler's successor, Hiroshi Nakajima. In 1998, Gro Harlem Brundtland, Figure 1 a former Prime Minister of Norway, took office and WHO began a period of major strategic and structural reform. Almost 4 years into her first term as director-general, I visited WHO's headquarters in Geneva to learn about Dr Brundtland's successes and failures. Figure 2 The ground rules of my visit were that I could talk with anybody and attend almost any meeting (budget discussions were excluded). I interviewed Dr Brundtland, executive directors, members of the staff association, and directors and project managers of programmes such as StopTB, Roll Back Malaria, HIV-AIDS, violence prevention, polio eradication, essential drugs and medicines, and sustainable development. At senior levels, WHO is confident and clear about its purpose-in a way that matches Mahler's vision and goes beyond it in results. Brundtland told me that her most important achievements were to have "strengthened the credibility of WHO" and to have "raised the awareness of health on to the political and global development agendas". But there is a troubling schism between the aspirations of its leadership and the realities faced by the organisation on the ground. Rapid change during the past 4 years has reinvigorated WHO's mandate, but poor management has created new tensions that the organisation's leadership seems unwilling to address.
Comment in
-
WHO: the casualties and compromises of renewal.Lancet. 2002 Sep 21;360(9337):953-4. doi: 10.1016/S0140-6736(02)11062-2. Lancet. 2002. PMID: 12354505 No abstract available.
Similar articles
-
The World Health Organisation. Interview with the director general. Interview by Fiona Godlee.BMJ. 1995 Mar 4;310(6979):583-6. doi: 10.1136/bmj.310.6979.583. BMJ. 1995. PMID: 7888938 Free PMC article.
-
WHO in crisis.BMJ. 1994 Nov 26;309(6966):1424-8. doi: 10.1136/bmj.309.6966.1424. BMJ. 1994. PMID: 7819856 Free PMC article.
-
Gro Harlem Brundtland could be the person to restore stability and credibility to the World Health Organization.Nurs Times. 1998 Feb 18-24;94(7):24. Nurs Times. 1998. PMID: 9536725 No abstract available.
-
Public health lives: Gro Harlem Brundtland.Public Health. 2014 Feb;128(2):148-50. doi: 10.1016/j.puhe.2013.08.007. Epub 2014 Jan 8. Public Health. 2014. PMID: 24411618 Review.
-
WHO at country level.Lancet. 1998 Mar 7;351(9104):743-7. doi: 10.1016/S0140-6736(97)12451-5. Lancet. 1998. PMID: 9504535 Review.
Cited by
-
Proposing a sequential comparative analysis for assessing multilateral health agency transformation and sustainable capacity: exploring the advantages of institutional theory.Global Health. 2014 May 20;10:38. doi: 10.1186/1744-8603-10-38. Global Health. 2014. PMID: 24886283 Free PMC article.
-
Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest.Implement Sci. 2012 Jul 4;7:60. doi: 10.1186/1748-5908-7-60. Implement Sci. 2012. PMID: 22762776 Free PMC article.
-
Transparent development of the WHO rapid advice guidelines.PLoS Med. 2007 May;4(5):e119. doi: 10.1371/journal.pmed.0040119. PLoS Med. 2007. PMID: 17535099 Free PMC article.
-
Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders.PLoS Med. 2010 Aug 31;7(8):e1000322. doi: 10.1371/journal.pmed.1000322. PLoS Med. 2010. PMID: 20824176 Free PMC article.
-
Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases.Curr Allergy Asthma Rep. 2011 Jun;11(3):261-8. doi: 10.1007/s11882-011-0185-8. Curr Allergy Asthma Rep. 2011. PMID: 21409613 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous